Literature DB >> 19953356

[Pediatric kidney transplantation].

G Offner1.   

Abstract

Kidney transplantation is the first line treatment for children with terminal renal failure. In addition to the survival rate of children and transplanted kidneys, the overall condition of the child with respect to growth and development is particularly important. The aims of pediatric renal transplantation are treatment strategies which minimize the side effects of immunosuppression and permit normal growth and development.

Entities:  

Mesh：

Year:  2009        PMID： 19953356     DOI： 10.1007/s00120-009-2163-5

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  10 in total

1.  The Role of Organ Transplantation in Pediatrics.

Authors:  Thomas E Starzl; Thomas L Marchioro; Ken A Porter; Tanous D Faris; Thomas A Carey
Journal:  Pediatr Clin North Am       Date:  1966       Impact factor: 3.278

2.  Non-compliance and transfer from paediatric to adult transplant unit.

Authors:  A R Watson
Journal:  Pediatr Nephrol       Date:  2000-06       Impact factor: 3.714

3.  Growth in children after kidney transplantation with living related donor graft or cadaveric graft.

Authors:  L Pape; J H H Ehrich; M Zivicnjak; G Offner
Journal:  Lancet       Date:  2005 Jul 9-15       Impact factor: 79.321

4.  [Kidney transplantation in children at Hannover from 1970 to 1977 (author's transl)].

Authors:  G Offner; M Brandis; J Brodehl; H P Krohn; R Pichlmayr; G Tidow
Journal:  Dtsch Med Wochenschr       Date:  1979-03-16       Impact factor: 0.628

Review 5.  Hypertension and end-organ damage in pediatric renal transplantation.

Authors:  Mark M Mitsnefes
Journal:  Pediatr Transplant       Date:  2004-08

6.  Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids.

Authors:  R A McDonald; J M Smith; M Ho; R Lindblad; D Ikle; P Grimm; R Wyatt; M Arar; D Liereman; N Bridges; W Harmon
Journal:  Am J Transplant       Date:  2008-05       Impact factor: 8.086

7.  Should pediatric patients wait for HLA-DR-matched renal transplants?

Authors:  H A Gritsch; J L Veale; A B Leichtman; M K Guidinger; J C Magee; R A McDonald; W E Harmon; F L Delmonico; R B Ettenger; J M Cecka
Journal:  Am J Transplant       Date:  2008-10       Impact factor: 8.086

8.  Risk factors for hypertension 3 years after renal transplantation in children.

Authors:  Samantha S Nagasako; Paulo C Koch Nogueira; Paula G P Machado; José O M Pestana
Journal:  Pediatr Nephrol       Date:  2007-05-30       Impact factor: 3.714

9.  Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.

Authors:  Gisela Offner; Burkhard Toenshoff; Britta Höcker; Manuela Krauss; Monika Bulla; Pierre Cochat; Henry Fehrenbach; Wolfgang Fischer; Michel Foulard; Bernd Hoppe; Peter F Hoyer; Therese C Jungraithmayr; Günter Klaus; Kay Latta; Heinz Leichter; Michael J Mihatsch; Joachim Misselwitz; Carmen Montoya; Dirk E Müller-Wiefel; Thomas J Neuhaus; Lars Pape; Uwe Querfeld; Christian Plank; Dieter Schwarke; Simone Wygoda; Lothar B Zimmerhackl
Journal:  Transplantation       Date:  2008-11-15       Impact factor: 4.939

10.  Urinary tract infections in children after renal transplantation.

Authors:  Ulrike John; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2008-01-16       Impact factor: 3.714
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.